drugset / Trial / NCT01789606

Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

NCT01789606

Phase 3 Completed 1083 enrolled Pfizer
NaSingle-groupOpen-labelTreatment

Summary

A self-selection and actual use trial to evaluate the extent to which consumers will appropriately select and use the 600 mg immediate release/extended release caplets and comply with dosing instructions.

Timeline

Start
2012-09-24
Primary completion
2013-06-03
Completion
2013-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 600 mg Oral

Indications

No indication recorded.